Keyphrases
Paclitaxel
100%
Cytotoxicity
100%
Gemcitabine
100%
Metabolism
100%
Human Lung Cancer Cell Line
100%
Sequence-dependent
100%
IC50
27%
Lung
9%
Non-small Cell Lung Cancer (NSCLC)
9%
Active Agent
9%
Cytotoxic Effect
9%
Apoptosis
9%
G2-M Arrest
9%
Antagonism
9%
Multiple Drugs
9%
Simultaneous Treatment
9%
DNA Flow Cytometry
9%
Drug Combination
9%
DNA Synthesis
9%
Additivity
9%
Active Metabolite
9%
Ribonucleotides
9%
Deoxycytidine Kinase
9%
Treatment Drugs
9%
Drug Effect Analysis
9%
Reverse Sequence
9%
Minor Effect
9%
H460
9%
S-phase Arrest
9%
Apoptotic Index
9%
Combination Index
9%
H322 Cells
9%
H460 Cells
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cell Cycle
100%
Metabolic Pathway
100%
Cytotoxicity
100%
Gemcitabine
100%
RNA
18%
Flow Cytometry
9%
Metabolite
9%
S Phase
9%
DNA Synthesis
9%
Drug Effect
9%
Deoxycytidine Kinase
9%
Ribonucleotide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Cytotoxicity
100%
Paclitaxel
100%
Gemcitabine
100%
Flow Cytometry
9%
Combination Drug
9%
Active Metabolite
9%
Ribonucleotide
9%
Deoxycytidine Kinase
9%